LifeStance Health Group, Inc.
General ticker "LFST" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $2.7B (TTM average)
LifeStance Health Group, Inc. follows the US Stock Market performance with the rate: 50.9%.
Estimated limits based on current volatility of 1.9%: low 12.08$, high 12.56$
Factors to consider:
- Total employees count: 10961 (+7.3%) as of 2025
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Management transition, Physician retention, Acquisition/divestiture risks, Regulatory and compliance, Cybersecurity threats
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.13$, 12.05$]
- 2026-12-31 to 2027-12-31 estimated range: [8.08$, 13.34$]
Financial Metrics affecting the LFST estimates:
- Positive: with PPE of 287.9 at the end of fiscal year the price was neutral
- Positive: 4.90 < Operating cash flow per share per price, % of 5.34
- Positive: 0.56 < Operating profit margin, % of 1.70
- Positive: -4.55 < Industry operating profit margin (median), % of -0.34
- Negative: 58.56 < Shareholder equity ratio, % of 69.01 <= 69.38
- Positive: 3.66 < Industry operating cash flow per share per price (median), % of 4.90
- Positive: -0.55 < Return on assets ratio (scaled to [-100,100]) of 0.44
- Negative: Industry earnings per price (median), % of 0 <= 0
- Positive: -2.60 < Investing cash flow per share per price, % of -1.32
- Positive: Interest expense per share per price, % of 0.43 <= 0.75
Short-term LFST quotes
Long-term LFST plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $1,055.66MM | $1,250.97MM | $1,424.29MM |
| Operating Expenses | $1,244.80MM | $1,282.58MM | $1,400.14MM |
| Operating Income | $-189.13MM | $-31.61MM | $24.15MM |
| Non-Operating Income | $-17.45MM | $-26.00MM | $-11.79MM |
| Interest Expense | $21.22MM | $26.54MM | $11.66MM |
| Income(Loss) | $-206.58MM | $-57.61MM | $12.36MM |
| Taxes | $-20.32MM | $-0.17MM | $2.70MM |
| Net Income(Loss)* | $-186.26MM | $-57.44MM | $9.66MM |
| Stockholders Equity | $1,428.93MM | $1,446.29MM | $1,521.02MM |
| Assets | $2,109.97MM | $2,118.30MM | $2,203.93MM |
| Operating Cash Flow | $-16.88MM | $107.26MM | $146.15MM |
| Capital expenditure | $40.52MM | $21.57MM | $36.12MM |
| Investing Cash Flow | $-60.34MM | $-21.57MM | $-36.12MM |
| Financing Cash Flow | $47.43MM | $-9.95MM | $-15.96MM |
| Earnings Per Share** | $-0.51 | $-0.15 | $0.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.